Related Experiment Video

Updated: Aug 23, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy

Soren Schenk1, Patrick M McCarthy, Randall C Starling

  • 1Department of Biomedical Engineering, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

The Journal of Thoracic and Cardiovascular Surgery
|June 30, 2004
PubMed

Insights

Left ventricular reconstruction surgery improved heart function and reduced neuroendocrine activation in patients with congestive heart failure. This surgical approach shows promise for managing heart failure by improving both cardiac performance and hormonal balance.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Neuroendocrine axis activation in congestive heart failure (CHF) has prognostic implications.
  • Neurohumoral blocking therapies are known to prolong survival in CHF patients.
  • The impact of surgical left ventricular volume reduction on neuroendocrine activation is not well-established.

Purpose of the Study:

  • To evaluate the neurohormonal response to left ventricular reconstruction surgery in patients with ischemic cardiomyopathy.
  • To assess the effect of surgical intervention on key neuroendocrine markers and cardiac function.

Main Methods:

  • Measured norepinephrine, plasma renin activity, and angiotensin II in 10 patients pre- and post-surgery.
  • Assessed brain natriuretic peptide in 5 additional patients.
  • Utilized 3D cardiovascular imaging to determine ejection fraction and left ventricular end-diastolic volume index.

Main Results:

  • Left ventricular reconstruction significantly improved New York Heart Association functional class, ejection fraction, and left ventricular end-diastolic volume index.
  • Substantial reductions were observed in plasma norepinephrine, plasma renin activity, angiotensin II, and brain natriuretic peptide levels post-surgery.
  • A greater decrease in plasma renin activity and angiotensin II correlated with a higher increase in ejection fraction.

Conclusions:

  • Surgical left ventricular reconstruction in CHF patients leads to improved cardiac function and reduced neuroendocrine activity.
  • The observed improvements in neurohormonal markers and functional status suggest a favorable response to the surgical intervention.
  • Further research is needed to determine if this neurohormonal response predicts improved long-term survival in CHF patients.
Abstract

More Related Videos

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...